Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
Open accessThe DOI matches its Crossref record; 288 of the 295 references it cites were found in a registry or an index.
Abstract
Melanoma is a highly aggressive cancer with the poorest prognosis, representing the deadliest form of skin cancer. Activating mutations in BRAF are the most frequent genetic alterations, present in approximately 50% of all melanoma cases. The use of specific inhibitors towards mutant BRAF variants and MEK, a downstream signaling target of BRAF in the MAPK pathway, has significantly improved progression-free and overall survival in advanced melanoma patients carrying BRAF mutations. Nevertheless, despite these improvements, resistance still develops within the first year of therapy in around 50% of patients, which is a significant problem in managing BRAF-mutated advanced melanoma. Understanding these mechanisms is one of the mainstreams of the research on BRAFi/MEKi acquired resistance. Both genetic and epigenetic mechanisms have been described. Moreover, in recent years, oxidative stress has emerged as another major force involved in all the phases of melanoma development, from initiation to progression until the onsets of the metastatic phenotype and chemoresistance, and has thus become a target for therapy. In the present review, we discuss the current knowledge on oxidative stress and its signaling in melanoma, as well as the oxidative stress-related mechanisms in the acquired resistance to targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is overwhelming evidence that oxidative stress plays a central role in the different stages of melanomagenesis [ 72 , 73 ].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Yang, P., Sun, D., & Jiang, F. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15149775533331 · Cited by 36
RetractedGao, W., Ge, S., & Sun, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.114 · Cited by 33
RetractedRETRACTED: Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells
Liu, W., Liu, X., Pan, Z., Wang, D., Li, M., Chen, X., Zhou, L., Xu, M., Li, D., & Zheng, Q. (2019) · Biomolecules · doi:10.3390/biom9070275 · Cited by 28
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“Globally, in 2020, new melanoma cases occurred in 324,635 people and resulted in 57,043 deaths [1].”
BackgroundMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 6×
“In particular, in BRAF V600E mutant melanoma, the MAPK activated pathway leads to hyperphosphorylation of FAM129B, which in turn can compete with Nrf2 for the binding to Keap1; in the absence of its inhibitor Keap1, Nrf2 protein is more stable; thus, its level can increase [155].”
BackgroundInfluentialImproved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · cited 2×
“This process is known as lipid peroxidation (LPO) and induces the formation of lipid radicals and other reactive intermediates (lipid radical L•, lipid peroxy radical L-OO•, lipid hydroperoxide L-OOH), as well as several highly reactive aldehydes, including 4-hydroxynonenal (HNE) and malondialdehyde (MDA), further amp…”
BackgroundNitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349 · cited 12×
“GSTs are a family of detoxification enzymes able to conjugate reduced GSH to a wide number of exogenous and endogenous electrophilic and hydrophobic substrates, participating in tumorigenic processes and drug resistance [169].”
BackgroundInfluentialRole of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Research works printed but not linked: 1
- Gracia-Sancho, J., and Salvadó, J. (2017). Oxidative Stress and Gut Microbiota. Gastrointestinal Tissue Oxidative Stress and Dietary Antioxidant, Academic Press. Chapter 8.
Cited by
Emanuelli, M., Sartini, D., Molinelli, E., Campagna, R., Pozzi, V., Salvolini, E., Simonetti, O., Campanati, A., & Offidani, A. (2022) · Antioxidants · doi:10.3390/antiox11040612 · Cited by 132
“Indeed, oxidative stress has emerged as an important player in all stages of melanoma, from genesis to progression until the development of the metastatic disease and chemoresistance, thus being a promising pathway for targeted therapy [18,19].”
BackgroundAir pollution and skin diseases: A comprehensive evaluation of the associated mechanism.
Gu, X., Li, Z., & Su, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116429 · Cited by 91
Oxidative Stress and Age-Related Tumors
Carlo, E. D., & Sorrentino, C. (2024) · Antioxidants · doi:10.3390/antiox13091109 · Cited by 112
“UV-induced oxidative stress is a major cause of skin cancers, including melanoma [196] and non-melanoma skin cancers [197].”
BackgroundOxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
Pomi, F. L., Gammeri, L., Borgia, F., Gioacchino, M. D., & Gangemi, S. (2025) · Antioxidants · doi:10.3390/antiox14050555 · Cited by 100
“The pharmacological inhibition of GPX4 or the depletion of its cofactor, glutathione, leads to the accumulation of oxidized lipid species, ultimately triggering ferroptosis [86].”
Attri, N., Das, S., Banerjee, J., Shamsuddin, S. H., Dash, S. K., & Pramanik, A. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00153 · Cited by 67
Argenziano, M., Bessone, F., Dianzani, C., Cucci, M. A., Grattarola, M., Pizzimenti, S., & Cavalli, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020341 · Cited by 42
“However, in recent years, researchers have focused their attention on oxidative stress being able to play a central role in tumor progression [10], including melanoma [11].”
BackgroundSelf-citationNRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
Carpenter, E. L., Becker, A. L., & Indra, A. K. (2022) · Cancers · doi:10.3390/cancers14061531 · Cited by 47
“We recently performed a high-throughput screen to identify compounds effective against drug-resistant melanoma and found that compounds that target the electron transport chain were the most potent and others have studied different compounds that act similarly [81,243].”
BackgroundMicrobiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
Azzimonti, B., Ballacchino, C., Zanetta, P., Cucci, M. A., Monge, C., Grattarola, M., Dianzani, C., Barrera, G., & Pizzimenti, S. (2023) · Antioxidants · doi:10.3390/antiox12030546 · Cited by 43
Self-citationOxidative Stress and Immune Response in Melanoma: Ion Channels as Targets of Therapy
Remigante, A., Spinelli, S., Marino, A., Pusch, M., Morabito, R., & Dossena, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010887 · Cited by 36
“, beta-carotene (vitamin A), alpha-ascorbic acid (vitamin C), tocopherol (vitamin E) [44].”
BackgroundInfluentialUpadhyay, P. R., Starner, R. J., Swope, V. B., Wakamatsu, K., Ito, S., & Abdel-Malek, Z. A. (2022) · Antioxidants · doi:10.3390/antiox11061204 · Cited by 30
“There is overwhelming evidence that oxidative stress plays a central role in the different stages of melanomagenesis [72,73].”
BackgroundThe dual role of Nrf2 in melanoma: a systematic review
Malakoutikhah, Z., Mohajeri, Z., Dana, N., & Javanmard, S. H. (2023) · BMC Molecular and Cell Biology · doi:10.1186/s12860-023-00466-5 · Cited by 32
“Nrf2 is released, translocated into the nucleus, binding to ARE (antioxidant response element) sequences in the promoter of genes coding for antioxidant enzymes such as HO-1 (heme-oxygenase-1), SOD (superoxide dismutase), CAT (catalase), and GPX (glutathione peroxidase) [10, 11].”
BackgroundRole of ROS‑mediated autophagy in melanoma (Review)
Zhang, X., Li, H., Liu, C., & Yuan, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12819 · Cited by 27
“However, the imbalance in ROS generation and removal causes excessive accumulation of ROS and thus oxidative stress, resulting in detrimental oxidative DNA damage, which is regarded as a major factor for carcinogenesis (4).”
BackgroundZhang, Y., Zhou, X., Cheng, X., Hong, X., Jiang, X., Jing, G., Chen, K., & Li, Y. (2022) · Neoplasma · doi:10.4149/neo_2022_220714n714 · Cited by 29
The Significance of Aldehyde Dehydrogenase 1 in Cancers
Nguyen, A. L., Facey, C. O. B., & Boman, B. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010251 · Cited by 32
Critical Review on Fatty Acid-Based Food and Nutraceuticals as Supporting Therapy in Cancer
Ferreri, C., Sansone, A., Chatgilialoglu, C., Rosaria, F., Amézaga, J., Caro, M., Arranz, S., & Tueros, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116030 · Cited by 23
m6A Modification—Association with Oxidative Stress and Implications on Eye Diseases
Ni, Y., Zhang, H., Chu, L., & Zhao, Y. (2023) · Antioxidants · doi:10.3390/antiox12020510 · Cited by 27
Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma
Zhang, J., Ye, Z., Chakraborty, P., Luo, Z., Culpepper, J., Aslam, M., Zhang, L., Johansson, K., Haeggström, J. Z., Xu, J., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106899 · Cited by 23
“…MEK-targeted therapies and anti-programmed death 1 (PD-1) or cytotoxic T-lymphocyte antigen 4 (CTLA-4) immune checkpoint inhibitors, many patients do not respond, or relapse after an initial response [4,5], emphasizing the need for additional novel therapeutic targets to improve existing therapies.”
BackgroundCardile, A., Zanrè, V., Campagnari, R., Asson, F., Addo, S. S., Orlandi, E., & Menegazzi, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021263 · Cited by 20
“BRAF- and MEK-inhibitors are highly effective targeted drugs in melanoma therapy, but they can induce drug resistance both in vitro and in patients [41].”
BackgroundTomi, E. D., Campagnari, R., Orlandi, E., Cardile, A., Zanrè, V., Menegazzi, M., Gomez‐Lira, M., & Gotte, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031647 · Cited by 15
“Activating mutations in the BRAF gene are the most frequent genomic alterations, present in more than half of all melanoma cases [24].”
BackgroundThe Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications
Hsu, C., Lee, K., Chiu, Y., Huang, K.-C., Wang, G., Chen, L.-P., Liao, K., & Lin, C. (2022) · Cells · doi:10.3390/cells11091492 · Cited by 15
“Compared to healthy tissue, melanoma has higher level of reactive oxidative species (ROS), which can damage DNA, proteins and lipids, resulting in senescence and cytotoxicity [14,15].”
BackgroundInoue, Y., Uchiyama, A., Amalia, S. N., Ishikawa, M., Kosaka, K., Sekiguchi, A., Ogino, S., Yokoyama, Y., Torii, R., Hosoi, M., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.06.202 · Cited by 15
Obrador, E., Palmer, R. S., López‐Blanch, R., Oriol‐Caballo, M., Moreno-Murciano, P., & Estrela, J. M. (2023) · Cells · doi:10.3390/cells12030418 · Cited by 19
Cheng, H., Li, S., Liu, H., Yan, M., Wang, J., Huang, J., Liu, S., Yang, Y., Cao, X., Cui, P., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02140-2 · Cited by 16
“It has been reported that CTLA-4 inhibits ROS production in tumour 30 and T cells 31 .”
Oxidative State in Cutaneous Melanoma Progression: A Question of Balance
Benedusi, M., Lee, H., Lim, Y., & Valacchi, G. (2024) · Antioxidants · doi:10.3390/antiox13091058 · Cited by 19
PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism
Garbarino, O., Valenti, G. E., Monteleone, L., Pietra, G., Mingari, M. C., Benzi, A., Bruzzone, S., Ravera, S., Leardi, R., Farinini, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1210130 · Cited by 14
Trzeciak, E. R., Zimmer, N., Gehringer, I., Stein, L., Graefen, B., Schupp, J., Stephan, A., Rietz, S., Prantner, M., & Tuettenberg, A. (2022) · Cells · doi:10.3390/cells11060930 · Cited by 14
“Due to their physical location, melanoma cells are directly exposed to a myriad of environmental oxidative stress inducing factors, like UV radiation [16,18].”
BackgroundUnveiling the intersection: ferroptosis in influenza virus infection
Letafati, A., Taghiabadi, Z., Ardekani, O. S., Abbasi, S., Najafabadi, A. Q., Jazi, N. N., Soheili, R., Rodrigo, R., Yavarian, J., & Saso, L. (2024) · Virology Journal · doi:10.1186/s12985-024-02462-3 · Cited by 16
“Nonenzymatic antioxidants include GSH, proteins like ferritin, TF, albumin, cerulo-plasmin, and molecules such as uric acid, coenzyme Q, and lipoic acid [73, 74].”
BackgroundMokrzynski, K. T., Sarna, M., & Sarna, T. (2023) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2023.112704 · Cited by 15
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
Cucci, M. A., Grattarola, M., Monge, C., Roetto, A., Barrera, G., Caputo, E., Dianzani, C., & Pizzimenti, S. (2023) · Antioxidants · doi:10.3390/antiox12061313 · Cited by 17
“Indeed, redox biology, which refers to the study of biochemical processes guided by reactive oxygen/nitrogen species (ROS and RNS) and antioxidants, plays a central role in melanoma and other solid cancers [12,13].”
BackgroundSelf-citationKyriakou, S., Potamiti, L., Demosthenous, N., Amery, T., Stewart, K., Winyard, P. G., Franco, R., Pappa, A., & Panayiotidis, M. I. (2023) · Nutrients · doi:10.3390/nu15184044 · Cited by 13
Nrf2 protein in melanoma progression, as a new means of treatment
Feng, Q., Xu, X., & Zhang, S. (2023) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13137 · Cited by 13
“…of reactive oxygen species (e.g., superoxide and hydrogen peroxide) and reactive nitrogen species (e.g., nitric oxide) include enzymes that are connected with NADPH oxidase (NOX) and nitric oxide synthase (NOS), respectively (Lin et al., 2023; Obrador et al., 2019; Pizzimenti et al., 2021).”
BackgroundReview: The Key Factors to Melanomagenesis
Mihulecea, C.-R., & Rotaru, M. (2023) · Life · doi:10.3390/life13010181 · Cited by 14
A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progression
Zhang, J., Ye, Z., Bräutigam, L., Chakraborty, P., Luo, Z., Culpepper, J., Aslam, M., Zhang, L., Johansson, K., Haeggström, J. Z., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104920 · Cited by 10
Kyriakou, S., Demosthenous, N., Amery, T., Stewart, K. J., Winyard, P. G., Franco, R., Pappa, A., & Panayiotidis, M. I. (2024) · Antioxidants · doi:10.3390/antiox13010082 · Cited by 10
“Previous studies have suggested that malignant melanoma cells are characterized by a dysregulated redox balance evident as higher basal ROS levels compared to non-tumorigenic keratinocytes and/or fibroblasts [41–43].”
Han, N., Park, H., Ko, S., & Moon, P. (2024) · Antioxidants · doi:10.3390/antiox13030380 · Cited by 15
Marcovici, I., Chioibaş, R., Zupkó, I., Pînzaru, I., Moacă, E.-A., Ledeţi, A., Barbu–Tudoran, L., Geamantan, A., Predescu, I.-A., & Dehelean, C. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1487854 · Cited by 10
“Oxidative stress plays a crucial role in different phases of melanomagenesis from tumor initiation and progression, to metastasis onset and chemoresistance development, CM exhibiting particularly elevated ROS levels compared to other solid cancers (Pizzimenti et al., 2021; Becker and Indra, 2023).”
The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy
Hajibabaie, F., Abedpoor, N., Javanmard, S. H., Hasan, A., Sharifi, M., Rahimmanesh, I., Shariati, L., & Makvandi, P. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116980 · Cited by 13
Lee, Y., Heo, J. Y., Kim, D. S., Choi, Y. S., Kim, S., Nam, H. S., Lee, S.-H., & Cho, M. K. (2023) · Annals of Dermatology · doi:10.5021/ad.22.200 · Cited by 11
Rong, D., Su, Y., Jia, D., Zeng, Z., Yang, Y., Wei, D., Lu, H., & Cao, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387316 · Cited by 10
“Moreover, our study delves into the impact of these genes on drug resistance and response to immunotherapy (67, 68).”
BackgroundCammann, C., Kulla, J., Wiebusch, L., Walz, C., Zhao, F., Lowinus, T., Topfstedt, E., Mishra, N., Henklein, P., Bommhardt, U., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115635 · Cited by 9
Ishikawa, M., Uchiyama, A., Kosaka, K., Nishio, M., Ogino, S., Yokoyama, Y., Torii, R., Akai, R., Iwawaki, T., Torii, S., et al. (2024) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2024.07.005 · Cited by 11
Haghmorad, D., Razavi, F. T., Eivazzadeh, Y., Yazdanpanah, E., & Orooji, N. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118364 · Cited by 13
Salgado, M. T. S. F., Silva, E. F. E., do Nascimento, M. A., Lopes, A. C., de Paiva, L. S., & Votto, A. P. D. S. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2241698 · Cited by 9
Fawal, G. F. E., & Abu-Serie, M. M. (2024) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-024-00527-w · Cited by 9
Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity
Sorrentino, C., Lauretta, C., D’Angiolo, R., Musella, S., Giovannelli, P., Bertamino, A., Ostacolo, C., Monterrey, I. G., Migliaccio, A., Castoria, G., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08469-8 · Cited by 7
“Given the high metabolic plasticity and robust antioxidant defenses of melanoma [69, 70], which contribute to resistance to targeted and immune-checkpoint therapies [71, 72], overwhelming the mitochondrial redox control may represent a strategy to bypass resistance.”
Patel, H. M., Mishra, R., Wier, A., Mokhtarpour, N., Merino, E. J., & Garrett, J. T. (2023) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001500 · Cited by 6
Redox Regulation and Oxidative Stress in Health and Disease: Mechanisms and Therapeutic Targeting
Azadi, M. H., Niknejad, A., & Amini, E. (2026) · MedComm – Future Medicine · doi:10.1002/mef2.70056 · Cited by 5
Ghosh, D., Das, T., Karmakar, S., Bhar, S., Kar, K., Mondal, S., Zangrando, E., Das, D., & Chandra, A. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.116001 · Cited by 4
Storsberg, J., Krüger‐Genge, A., & Kalitukha, L. (2022) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2022044657 · Cited by 4
Soares, J. P. M., Gonçalves, D. A., de Sousa, R. X., Mouro, M. G., Higa, E. M. S., Sperandio, L. P., Vitoriano, C. M., Rosa, E. B. S., dos Santos, F. O., de Queiroz, G. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115979 · Cited by 7
“On the other hand, it is known that high concentrations of ROS can lead to cell death; thus, tumor cells can increase the antioxidant system to protect and ensure tumor progression [50,51,77].”
BackgroundAkbari, M., Toolabi, M., Malek-Khatabi, A., Eskandari, M. R., Chen, B. Z., Guo, X. D., & Shahbazi, M. (2025) · Materials Advances · doi:10.1039/d5ma00623f · Cited by 3
Sun, Y., Yu, H., Zhou, Y., Bao, J., & Qian, X. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-03895-8 · Cited by 3
“Melanoma, a skin cancer derived from melanocytes, has not only exhibited a continuous increase in incidence but also stands as the deadliest form of skin cancer, owing to its high invasiveness and metastatic potential [1].”
Kozyra, P., Humeniuk, E., Arczewska, M., Adamczuk, G., Gagoś, M., Korga-Plewko, A., & Pitucha, M. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108736 · Cited by 2
Natural plant oil-based drug delivery systems influence melanoma growth in in vitro studies
Duque, M. S. R. V., Renn, P., Oliva, A., & de Barros, D. P. C. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108240 · Cited by 2
Sabău, A.-H., Niculescu, R., Cocuz, I. G., Tinca, A. C., Cozac-Szőke, A. R., Lazar, B. A., Chiorean, D. M., Budin, C. E., Tomuț, A. N., & Cotoi, O. S. (2024) · Medicina · doi:10.3390/medicina60101658 · Cited by 2
“Its expression has been associated with increased tumor aggressiveness, a more reserved prognosis, and reduced effectiveness of BRAF inhibitor therapies [14].”
BackgroundZhou, C., Zhong, R., Zhang, L., Yang, R., Luo, Y., Lei, H., Li, L., Cao, J., Yuan, Z., Tan, X., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-01784-0 · Cited by 4
Vangala, V., Chen, Y., Dinavahi, S. S., Gowda, K., Lone, N., Herlyn, M., Drabick, J. J., Helm, K. F., Zhu, J., Neves, R. I., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00453 · Cited by 3
Hua, L., Huang, L., Wan, H., & Chen, M. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167762 · Cited by 2
Zhang, D., Ren, X., Zhang, K., Hu, Y., Wang, C., Zhao, G., Liu, J., & Sun, X. (2025) · Journal of Food Biochemistry · doi:10.1155/jfbc/7630023 · Cited by 1
de Oliveira, T. A. D., Ribeiro, R. S. N., Laiso, R. A. N., Alves, M. G., Sousa, Y. E. M., de Matos, Í. G. T. P., Rabelo, D. D. C., Rici, R. E. G., Chammas, S. M., Afeche, S. C., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1753894 · Cited by 1
“Melanoma depends on profound metabolic rewiring to sustain proliferation, resist oxidative stress, and evade apoptosis (Pizzimenti et al., 2021).”
Hong, X., Wen, X., Zhang, T., Liu, Y., 纪宇, & Shen, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790210 · Cited by 1
Malondialdehyde and Oxidative Stress in Cancer: Biological Insights and Clinical Perspectives
Pomi, F. L., Silva, M. C. G. D. S., Murdaca, G., Borgia, F., Bottaro, A., Gangemi, S., & Allegra, A. (2026) · Biomedicines · doi:10.3390/biomedicines14081696 · Cited by 2
“However, MDA remains a non-specific marker and may be influenced by age, smoking, diet, metabolic disease, systemic inflammation, and analytical methodology, especially when quantified using thiobarbituric acid reactive substances assays [120,121].”
Marengo, B., Angeli, J. P. F., & Domenicotti, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1260233 · Cited by 1
Cellular response to compartmentalized redox alterations
Revazian, A. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9408
Investigating the function of NR4A3 in melanocyte DNA repair and cyto-protection
Pavarino, A. C. D. A. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.248364 · Cited by 1
Yang, L., Yang, L., He, Y., Peng, Y., Mao, S., Tang, Z., Du, L., Zhou, W., Yang, D., & Wu, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5132031
Ramanathan, P., Shah, A., Kasturi, N., Srinivas, B. H., & Kaur, K. P. (2025) · Indian Journal of Ophthalmology - Case Reports · doi:10.4103/ijo.ijo_2226_24
Abubakari, S., Dizman, Y. A., & Karaman, F. (2025) · Diagnostics · doi:10.3390/diagnostics15141770 · Cited by 4
Neuendorf, H. M., He, X., Adams, M. N., Chow, S., Tran, K. A., Smith, A. G., Bernhardt, P. V., Williams, C. M., Simmons, J. L., & Boyle, G. M. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03819-y · Cited by 1
Huner, I. B., Kirac, M. K., & Ülgen, K. Ö. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100465
Melanoma resists chemotherapy through an adaptive mitochondrial response
Zarei, M., Ali, S. A., Loftus, A. W., Nakazzi, F., Graor, H. J., Prajapati, O., Abul-Khoudoud, S. O., Asara, J. M., Wang, R., Winter, J. M., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03685-8
“These data contribute to the perception that melanoma is generally “chemoresistant”, with implicated mechanisms for resistance including dysregulated DNA repair pathways and adaptations to oxidative stress [18–20].”
Nosareva, O. L., Pomytkina, E. A., Korotkova, O. N., Tumanova, A. V., Stepovaya, E. A., Nagaitsev, V. М., Kochurina, E. A., Bakina, O. V., Kokorev, O. V., & Спирина, Л. В. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050434
“One reason for the unfavorable therapeutic prognosis is the activation of signaling pathways that enhance tumor cell survival [5,7,10,11].”
InfluentialSekily, M. A. E., Mancy, S. H., & Hamada, N. M. M. (2026) · International Journal of Organic Chemistry · doi:10.4236/ijoc.2026.162004
Impact of smoking on melanoma prognosis and survival
Srivastava, G., & Srivastava, G. (2026) · Academia oncology. · doi:10.20935/acadonco8516
Buligan, C., Petris, G., Stinco, G., & Cauci, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188395
“However, discrepancies still exist across cancer studies, particularly regarding proposed use of pro-or anti-oxidative stress strategies, which appear to be highly context-dependent [19,24,25].”
Lauretta, C., Sorrentino, C., Sabbatino, E., Tutino, V., Souza, D. S., MIGLIACCIO, A., Castoria, G., Giovannelli, P., & Donato, M. D. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1905416
“Nutrient depletion, oxidative stress, ROS accumulation, hypoxia, ER stress collectively promote stress tolerance, metabolic flexibility, and immune dysfunction (Cubillos-Ruiz and Glimcher, 2015; Almeida et al., 2019; Pizzimenti et al., 2021; Sabău et al., 2025).”
Karakousis, V. A., Sioga, A., Vizirianakis, I. S., Kesisoglou, I., Kosmidis, C. S., Pavlidis, L. C., & Papamitsou, T. (2026) · Cells · doi:10.3390/cells15191760
“Pharmacologically induced oxidative stress, via Signal Transducer and Activator of Transcription (STAT3) suppression, produces identical ultrastructural signatures [100], and similar damage has been reported with complex I inhibition [91,101].”
Stoica, B. A., Constantinescu, V. A., Knieling, A., Foia, L. G., Stoica, L., Minea, B., Ciureanu, I.-A., Leferman, C.-E., Olariu, O., Foia, C. I., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19101549
Naidek, A. F., Rodrigues, M. L., Stipp, M. C., Claudino, D. D. J. D. S., Echevarrı́a, A., Cadena, S. S. C., & Acco, A. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05970-x
Metadata
- Authors
- Pizzimenti, S., Ribero, S., Cucci, M. A., Grattarola, M., Monge, C., Dianzani, C., Barrera, G., & Muzio, G.
- Affiliations
- University of Turin (IT)
- Department of Clinical and Biological Science, University of Turin, 10125 Turin, Italy
- Corresponding author
- Pizzimenti, Stefania
- ORCID
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-12-03
- Volume
- 10
- Issue
- 12
- Pages
- 1942
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC8750393
- OpenAlex
- W4200547360
- Cited by
- 79
- References
- 295
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 14 · 2023: 21 · 2022: 13
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Dipartimenti di Eccellenza (Dipartimenti di Eccellenza 2018-2022, 2018–2022, D15D18000410001)
- Ministero dell’Istruzione, dell’Università e della Ricerca (20182022, D15D18000410001, “Dipartimenti di Eccellenza - 2018-2022”)
- Università degli Studi di Torino (2019.2252, D15D18000410001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- melanoma, oxidative stress, acquired drug resistance, BRAF inhibitors, MEK inhibitors, BRAF mutation, MAPK signaling, epigenetic mechanisms, chemoresistance, metastasis, antioxidant signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.